My Quote Request
No products added yet
6505-01-497-5520
20 Products
NDC62794-0111-98
MAFENIDE ACETATE,US
NSN, MFG P/N
6505014975520
NSN
6505-01-497-5520
MFG
MYLAN BERTEK PHARMACEUTICALS INC
Description
III AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 840416
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MAFENIDE ACETATE USP 50GM PACKET 5S
SPECIAL FEATURES: WHITE CRYSTALLINE POWDER PROVIDED IN PACKETS CONTAINING 50G OF STERILE MAFINIDE ACETATE; TO BE RECONSTITUTED IN 1000ML OF STERILE WATER; ANTIMICROBIAL PREPERATION FOR TOPICAL USE ONLY, NOT FOR INJECTION; STORE RECONSTITUTED SOLUTION AT 68 TO 77 DEG. F;
~1: UNOPENED PREPERATION MAY BE HELD UP TO 28 DAYS; IF OPENED DISCARD AFTER 48 HRS; PKG OF 5/50G PACKETS; STORE PKTS IN DRY PLACE AT 59 TO 86 DEG. F
Related Searches:
6505NCM000071
MAFENIDE ACETATE,US
NSN, MFG P/N
6505014975520
NSN
6505-01-497-5520
MFG
DEFENSE MEDICAL STANDARDIZATION BOARD
Description
III AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 840416
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MAFENIDE ACETATE USP 50GM PACKET 5S
SPECIAL FEATURES: WHITE CRYSTALLINE POWDER PROVIDED IN PACKETS CONTAINING 50G OF STERILE MAFINIDE ACETATE; TO BE RECONSTITUTED IN 1000ML OF STERILE WATER; ANTIMICROBIAL PREPERATION FOR TOPICAL USE ONLY, NOT FOR INJECTION; STORE RECONSTITUTED SOLUTION AT 68 TO 77 DEG. F;
~1: UNOPENED PREPERATION MAY BE HELD UP TO 28 DAYS; IF OPENED DISCARD AFTER 48 HRS; PKG OF 5/50G PACKETS; STORE PKTS IN DRY PLACE AT 59 TO 86 DEG. F
Related Searches:
02-0811
MAGNESIUM SULFATE INJECTION,USP
NSN, MFG P/N
6505014975663
NSN
6505-01-497-5663
02-0811
MAGNESIUM SULFATE INJECTION,USP
NSN, MFG P/N
6505014975663
NSN
6505-01-497-5663
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 MILLILITERS MAGNESIUM SULFATE PER MILLILITER
ADMINISTRATION: INTRAVENOUS
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 281292
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MAGNESIUM SULFATE INJECTION USP 2ML VIAL 25S
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: 4 MEQ/ML; STORE AT CONTROL ROOM TEMPERATURE 15 TO 30 DEGREES C (59 TO 86 DEGREES F)
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
6505NCM000186
MAGNESIUM SULFATE INJECTION,USP
NSN, MFG P/N
6505014975663
NSN
6505-01-497-5663
6505NCM000186
MAGNESIUM SULFATE INJECTION,USP
NSN, MFG P/N
6505014975663
NSN
6505-01-497-5663
MFG
DEFENSE MEDICAL STANDARDIZATION BOARD
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 MILLILITERS MAGNESIUM SULFATE PER MILLILITER
ADMINISTRATION: INTRAVENOUS
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 281292
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MAGNESIUM SULFATE INJECTION USP 2ML VIAL 25S
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: 4 MEQ/ML; STORE AT CONTROL ROOM TEMPERATURE 15 TO 30 DEGREES C (59 TO 86 DEGREES F)
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
NDC63323-0064-02
MAGNESIUM SULFATE INJECTION,USP
NSN, MFG P/N
6505014975663
NSN
6505-01-497-5663
NDC63323-0064-02
MAGNESIUM SULFATE INJECTION,USP
NSN, MFG P/N
6505014975663
NSN
6505-01-497-5663
MFG
CARDINAL HEALTH INC. DBA CARDINAL HEALTH
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 MILLILITERS MAGNESIUM SULFATE PER MILLILITER
ADMINISTRATION: INTRAVENOUS
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 281292
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MAGNESIUM SULFATE INJECTION USP 2ML VIAL 25S
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: 4 MEQ/ML; STORE AT CONTROL ROOM TEMPERATURE 15 TO 30 DEGREES C (59 TO 86 DEGREES F)
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
02-0560
PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM FOR INJECTION
NSN, MFG P/N
6505014976018
NSN
6505-01-497-6018
02-0560
PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM FOR INJECTION
NSN, MFG P/N
6505014976018
NSN
6505-01-497-6018
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 3.000 MILLIGRAMS PIPERACILLIN EQUIVALENT PER GRAM AND 0.375 MILLIGRAMS TAZOBACTAM EQUIVALENT PER GRAM
ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PIPERACILLIN/TOZOBACTAM SODIUM FOR INJECTION 10S
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: EACH ADD-VANTAGE VIAL CONTAINS 7.04 MEQ OF SODIUM; FOR HOSPITAL PATIENTS WITH SERIOUS INFECTIONS; ZOYSN IS PRESERVATIVE FREE; VIALS SHOULD BE STORED AT CONTROLLED ROOM TEMPERATURE 20 TO 25 DEGREES C (68 TO 77 DEGREES F) PRIOR TO RECONSTITUTION
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
6505NCM010330
PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM FOR INJECTION
NSN, MFG P/N
6505014976018
NSN
6505-01-497-6018
6505NCM010330
PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM FOR INJECTION
NSN, MFG P/N
6505014976018
NSN
6505-01-497-6018
MFG
DEFENSE MEDICAL STANDARDIZATION BOARD
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 3.000 MILLIGRAMS PIPERACILLIN EQUIVALENT PER GRAM AND 0.375 MILLIGRAMS TAZOBACTAM EQUIVALENT PER GRAM
ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PIPERACILLIN/TOZOBACTAM SODIUM FOR INJECTION 10S
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: EACH ADD-VANTAGE VIAL CONTAINS 7.04 MEQ OF SODIUM; FOR HOSPITAL PATIENTS WITH SERIOUS INFECTIONS; ZOYSN IS PRESERVATIVE FREE; VIALS SHOULD BE STORED AT CONTROLLED ROOM TEMPERATURE 20 TO 25 DEGREES C (68 TO 77 DEGREES F) PRIOR TO RECONSTITUTION
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00206-8454-17
PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM FOR INJECTION
NSN, MFG P/N
6505014976018
NSN
6505-01-497-6018
NDC00206-8454-17
PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM FOR INJECTION
NSN, MFG P/N
6505014976018
NSN
6505-01-497-6018
MFG
WYETH
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 3.000 MILLIGRAMS PIPERACILLIN EQUIVALENT PER GRAM AND 0.375 MILLIGRAMS TAZOBACTAM EQUIVALENT PER GRAM
ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PIPERACILLIN/TOZOBACTAM SODIUM FOR INJECTION 10S
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: EACH ADD-VANTAGE VIAL CONTAINS 7.04 MEQ OF SODIUM; FOR HOSPITAL PATIENTS WITH SERIOUS INFECTIONS; ZOYSN IS PRESERVATIVE FREE; VIALS SHOULD BE STORED AT CONTROLLED ROOM TEMPERATURE 20 TO 25 DEGREES C (68 TO 77 DEGREES F) PRIOR TO RECONSTITUTION
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
ZOSYN
PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM FOR INJECTION
NSN, MFG P/N
6505014976018
NSN
6505-01-497-6018
ZOSYN
PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM FOR INJECTION
NSN, MFG P/N
6505014976018
NSN
6505-01-497-6018
MFG
WYETH-AYERST LABORATORIES ORDER DEPT
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 3.000 MILLIGRAMS PIPERACILLIN EQUIVALENT PER GRAM AND 0.375 MILLIGRAMS TAZOBACTAM EQUIVALENT PER GRAM
ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PIPERACILLIN/TOZOBACTAM SODIUM FOR INJECTION 10S
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: EACH ADD-VANTAGE VIAL CONTAINS 7.04 MEQ OF SODIUM; FOR HOSPITAL PATIENTS WITH SERIOUS INFECTIONS; ZOYSN IS PRESERVATIVE FREE; VIALS SHOULD BE STORED AT CONTROLLED ROOM TEMPERATURE 20 TO 25 DEGREES C (68 TO 77 DEGREES F) PRIOR TO RECONSTITUTION
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
02-0539
RIBAVIRIN AND INTER
NSN, MFG P/N
6505014977883
NSN
6505-01-497-7883
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
III END ITEM IDENTIFICATION: FOR THE TREATMENT OF CHRONIC HEPATITIS C IN PATIENTS WITH COMPENSATED LIVER DISEASE PREVIOUSLY UNTREATED WITH ALPHA INTERFERON OR WHO HAVE RELAPSED FOLLOWING ALPHA INTERFERON THERAPY
III PART NAME ASSIGNED BY CONTROLLING AGENCY: RIBAVIRIN & INTERFERON COMBINATION PACK
SPECIAL FEATURES: 1 UNIT DOSE VIAL OF INTERFERON ALPHA-2B, 3 MILLION UNITS/0.5ML, 18 MILLION UNITS/VIALS; 42 CAPSULES OF RIBAVIRIN, 200 MG CAPSULE; INTERFERON SHOULD BE ADMINISTERED SUBCUTANEOUSLY AND RIBAVIRIN CAPSULES SHOULD BE ADMINISTERED ORALLY; REFRIGERATE RIBAVIRIN
~1: CAPSULES AND INTERFERON PACKAGE BETWEEN 2 AND 8 DEGREES C (36 AND 46 DEGREES F)
Related Searches:
6505NCM010332
RIBAVIRIN AND INTER
NSN, MFG P/N
6505014977883
NSN
6505-01-497-7883
MFG
DEFENSE MEDICAL STANDARDIZATION BOARD
Description
III END ITEM IDENTIFICATION: FOR THE TREATMENT OF CHRONIC HEPATITIS C IN PATIENTS WITH COMPENSATED LIVER DISEASE PREVIOUSLY UNTREATED WITH ALPHA INTERFERON OR WHO HAVE RELAPSED FOLLOWING ALPHA INTERFERON THERAPY
III PART NAME ASSIGNED BY CONTROLLING AGENCY: RIBAVIRIN & INTERFERON COMBINATION PACK
SPECIAL FEATURES: 1 UNIT DOSE VIAL OF INTERFERON ALPHA-2B, 3 MILLION UNITS/0.5ML, 18 MILLION UNITS/VIALS; 42 CAPSULES OF RIBAVIRIN, 200 MG CAPSULE; INTERFERON SHOULD BE ADMINISTERED SUBCUTANEOUSLY AND RIBAVIRIN CAPSULES SHOULD BE ADMINISTERED ORALLY; REFRIGERATE RIBAVIRIN
~1: CAPSULES AND INTERFERON PACKAGE BETWEEN 2 AND 8 DEGREES C (36 AND 46 DEGREES F)
Related Searches:
NDC00085-1236-03
RIBAVIRIN AND INTER
NSN, MFG P/N
6505014977883
NSN
6505-01-497-7883
MFG
SCHERING-PLOUGH CORPORATION
Description
III END ITEM IDENTIFICATION: FOR THE TREATMENT OF CHRONIC HEPATITIS C IN PATIENTS WITH COMPENSATED LIVER DISEASE PREVIOUSLY UNTREATED WITH ALPHA INTERFERON OR WHO HAVE RELAPSED FOLLOWING ALPHA INTERFERON THERAPY
III PART NAME ASSIGNED BY CONTROLLING AGENCY: RIBAVIRIN & INTERFERON COMBINATION PACK
SPECIAL FEATURES: 1 UNIT DOSE VIAL OF INTERFERON ALPHA-2B, 3 MILLION UNITS/0.5ML, 18 MILLION UNITS/VIALS; 42 CAPSULES OF RIBAVIRIN, 200 MG CAPSULE; INTERFERON SHOULD BE ADMINISTERED SUBCUTANEOUSLY AND RIBAVIRIN CAPSULES SHOULD BE ADMINISTERED ORALLY; REFRIGERATE RIBAVIRIN
~1: CAPSULES AND INTERFERON PACKAGE BETWEEN 2 AND 8 DEGREES C (36 AND 46 DEGREES F)
Related Searches:
REBETRON 600
RIBAVIRIN AND INTER
NSN, MFG P/N
6505014977883
NSN
6505-01-497-7883
MFG
SCHERING-PLOUGH CORPORATION
Description
III END ITEM IDENTIFICATION: FOR THE TREATMENT OF CHRONIC HEPATITIS C IN PATIENTS WITH COMPENSATED LIVER DISEASE PREVIOUSLY UNTREATED WITH ALPHA INTERFERON OR WHO HAVE RELAPSED FOLLOWING ALPHA INTERFERON THERAPY
III PART NAME ASSIGNED BY CONTROLLING AGENCY: RIBAVIRIN & INTERFERON COMBINATION PACK
SPECIAL FEATURES: 1 UNIT DOSE VIAL OF INTERFERON ALPHA-2B, 3 MILLION UNITS/0.5ML, 18 MILLION UNITS/VIALS; 42 CAPSULES OF RIBAVIRIN, 200 MG CAPSULE; INTERFERON SHOULD BE ADMINISTERED SUBCUTANEOUSLY AND RIBAVIRIN CAPSULES SHOULD BE ADMINISTERED ORALLY; REFRIGERATE RIBAVIRIN
~1: CAPSULES AND INTERFERON PACKAGE BETWEEN 2 AND 8 DEGREES C (36 AND 46 DEGREES F)
Related Searches:
02-0822
NEOSTIGMINE METHYLSULFATE INJECTION,USP
NSN, MFG P/N
6505014977913
NSN
6505-01-497-7913
02-0822
NEOSTIGMINE METHYLSULFATE INJECTION,USP
NSN, MFG P/N
6505014977913
NSN
6505-01-497-7913
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 MILLIGRAMS NEOSTIGMINE METHYLSULFATE PER MILLILITER
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 120400
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NEOSTIGMINE METHYLSULFATE INJECTION USP 1MG/ML 10ML VIAL 10S
III SUPPLEMENTARY FEATURES: STORE AT ROOM TEMERATURE (59-86 DEG F)
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: STORE IN SHELF PACK UNTIL TIME OF USE; PROTECT FROM LIGHT; 1:1000,10'S
Related Searches:
NDC10019-0270-10
NEOSTIGMINE METHYLSULFATE INJECTION,USP
NSN, MFG P/N
6505014977913
NSN
6505-01-497-7913
NDC10019-0270-10
NEOSTIGMINE METHYLSULFATE INJECTION,USP
NSN, MFG P/N
6505014977913
NSN
6505-01-497-7913
MFG
BAXTER HEALTHCARE CORPORATION DIV MEDICATION DELIVERY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 MILLIGRAMS NEOSTIGMINE METHYLSULFATE PER MILLILITER
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 120400
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NEOSTIGMINE METHYLSULFATE INJECTION USP 1MG/ML 10ML VIAL 10S
III SUPPLEMENTARY FEATURES: STORE AT ROOM TEMERATURE (59-86 DEG F)
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: STORE IN SHELF PACK UNTIL TIME OF USE; PROTECT FROM LIGHT; 1:1000,10'S
Related Searches:
02-0845
GLOBULIN,RHO (D) IMMUNE,FOR INJECTION
NSN, MFG P/N
6505014979072
NSN
6505-01-497-9072
02-0845
GLOBULIN,RHO (D) IMMUNE,FOR INJECTION
NSN, MFG P/N
6505014979072
NSN
6505-01-497-9072
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: GLOBULIN RHO (D) IMMUNE FOR INJECTION SYRINGE 5S
IMMEDIATE CONTAINER TYPE: SYRINGE
SPECIAL FEATURES: ULTRA-FILTERED 50 UG; PRESERVATIVE FREE; LATEX FREE DELIVERY SYSTEM; FOR INTRAMUSCULAR USE ONLY; CONTAINS: (5) PREFILLED SINGLE-DOSE SYRINGES OF MICRHOGAM; (5) PACKAGE INSERTS; (5) CONTROL FORMS; AND (5) PATIENT IDENTIFICATIONS CARDS; STORE AT 2 TO 8
UNIT PACKAGE QUANTITY: 5
UNIT PACKAGE TYPE: PACKAGE
~1: DEGREES C; DO NOT STORE FROZEN
Related Searches:
6505NCM990154
GLOBULIN,RHO (D) IMMUNE,FOR INJECTION
NSN, MFG P/N
6505014979072
NSN
6505-01-497-9072
6505NCM990154
GLOBULIN,RHO (D) IMMUNE,FOR INJECTION
NSN, MFG P/N
6505014979072
NSN
6505-01-497-9072
MFG
DEFENSE MEDICAL STANDARDIZATION BOARD
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: GLOBULIN RHO (D) IMMUNE FOR INJECTION SYRINGE 5S
IMMEDIATE CONTAINER TYPE: SYRINGE
SPECIAL FEATURES: ULTRA-FILTERED 50 UG; PRESERVATIVE FREE; LATEX FREE DELIVERY SYSTEM; FOR INTRAMUSCULAR USE ONLY; CONTAINS: (5) PREFILLED SINGLE-DOSE SYRINGES OF MICRHOGAM; (5) PACKAGE INSERTS; (5) CONTROL FORMS; AND (5) PATIENT IDENTIFICATIONS CARDS; STORE AT 2 TO 8
UNIT PACKAGE QUANTITY: 5
UNIT PACKAGE TYPE: PACKAGE
~1: DEGREES C; DO NOT STORE FROZEN
Related Searches:
780810
GLOBULIN,RHO (D) IMMUNE,FOR INJECTION
NSN, MFG P/N
6505014979072
NSN
6505-01-497-9072
780810
GLOBULIN,RHO (D) IMMUNE,FOR INJECTION
NSN, MFG P/N
6505014979072
NSN
6505-01-497-9072
MFG
ORTHO-CLINICAL DIAGNOSTICS INC.
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: GLOBULIN RHO (D) IMMUNE FOR INJECTION SYRINGE 5S
IMMEDIATE CONTAINER TYPE: SYRINGE
SPECIAL FEATURES: ULTRA-FILTERED 50 UG; PRESERVATIVE FREE; LATEX FREE DELIVERY SYSTEM; FOR INTRAMUSCULAR USE ONLY; CONTAINS: (5) PREFILLED SINGLE-DOSE SYRINGES OF MICRHOGAM; (5) PACKAGE INSERTS; (5) CONTROL FORMS; AND (5) PATIENT IDENTIFICATIONS CARDS; STORE AT 2 TO 8
UNIT PACKAGE QUANTITY: 5
UNIT PACKAGE TYPE: PACKAGE
~1: DEGREES C; DO NOT STORE FROZEN
Related Searches:
MICRHOGAM
GLOBULIN,RHO (D) IMMUNE,FOR INJECTION
NSN, MFG P/N
6505014979072
NSN
6505-01-497-9072
MICRHOGAM
GLOBULIN,RHO (D) IMMUNE,FOR INJECTION
NSN, MFG P/N
6505014979072
NSN
6505-01-497-9072
MFG
ORTHO-CLINICAL DIAGNOSTICS INC.
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: GLOBULIN RHO (D) IMMUNE FOR INJECTION SYRINGE 5S
IMMEDIATE CONTAINER TYPE: SYRINGE
SPECIAL FEATURES: ULTRA-FILTERED 50 UG; PRESERVATIVE FREE; LATEX FREE DELIVERY SYSTEM; FOR INTRAMUSCULAR USE ONLY; CONTAINS: (5) PREFILLED SINGLE-DOSE SYRINGES OF MICRHOGAM; (5) PACKAGE INSERTS; (5) CONTROL FORMS; AND (5) PATIENT IDENTIFICATIONS CARDS; STORE AT 2 TO 8
UNIT PACKAGE QUANTITY: 5
UNIT PACKAGE TYPE: PACKAGE
~1: DEGREES C; DO NOT STORE FROZEN
Related Searches:
NDC00562-7808-06
GLOBULIN,RHO (D) IMMUNE,FOR INJECTION
NSN, MFG P/N
6505014979072
NSN
6505-01-497-9072
NDC00562-7808-06
GLOBULIN,RHO (D) IMMUNE,FOR INJECTION
NSN, MFG P/N
6505014979072
NSN
6505-01-497-9072
MFG
ORTHO-CLINICAL DIAGNOSTICS INC.
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: GLOBULIN RHO (D) IMMUNE FOR INJECTION SYRINGE 5S
IMMEDIATE CONTAINER TYPE: SYRINGE
SPECIAL FEATURES: ULTRA-FILTERED 50 UG; PRESERVATIVE FREE; LATEX FREE DELIVERY SYSTEM; FOR INTRAMUSCULAR USE ONLY; CONTAINS: (5) PREFILLED SINGLE-DOSE SYRINGES OF MICRHOGAM; (5) PACKAGE INSERTS; (5) CONTROL FORMS; AND (5) PATIENT IDENTIFICATIONS CARDS; STORE AT 2 TO 8
UNIT PACKAGE QUANTITY: 5
UNIT PACKAGE TYPE: PACKAGE
~1: DEGREES C; DO NOT STORE FROZEN
